Kevin Bitterman's Net Worth

$106 Million

Estimate Recalculated Jul 10, 2024 03:16PM EST

Who is Kevin Bitterman?

Kevin Bitterman has an estimated net worth of $106 Million. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Akero Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., and Disc Medicine, Inc..

SEC CIK

Kevin Bitterman's CIK is 0001591747

Past Insider Trading and Trends

2014 was Kevin Bitterman's most active year for acquiring shares with 6 total transactions. Kevin Bitterman's most active month to acquire stocks was the month of January. 2016 was Kevin Bitterman's most active year for disposing of shares, totalling 13 transactions. Kevin Bitterman's most active month to dispose stocks was the month of November. 2019 saw Kevin Bitterman paying a total of $4,320,000.00 for 4,000,858 shares, this is the most they've acquired in one year. In 2017 Kevin Bitterman cashed out on 1,000,000 shares for a total of $17,000,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Editas Medicine, Inc. (EDIT) Snapshot price: $7.16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
-26.34%
-1.00M
$17.00
-$17,000,000.00
2.8M
May 22
Form 4
-1.94%
-75.00K
$15.82
-$1,186,500.00
3.8M
Dec 7
Form 4
-3.25%
-130.00K
$15.79
-$2,052,700.00
3.87M
Dec 5 - Dec 6
Form 4
-0.53%
-21.48K
$15.71
-$337,450.80
4M
Nov 23
Form 4
-0.32%
-12.82K
$15.77
-$202,155.63
4.02M
Nov 22
Form 4
-0.76%
-30.83K
$16.30
-$502,529.00
4.04M
Nov 16
Form 4
-2.14%
-88.90K
$16.96
-$1,507,308.89
4.07M
Nov 14 - Nov 15
Form 4
-10.74%
-500.00K
$16.80
-$8,400,000.00
4.16M
Sep 8
Form 4
∞
4.66M
—
—
4.66M
Feb 8
Form 3
—
0
—
—
0
No matching records found

Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-17.49K
$26.28
-$459,610.92
0
Scheduled
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
-52.46%
-13.00K
$28.93
-$376,090.00
11.78K
Oct 9
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Nov 8
Form 4
∞
3.97M
$16.00
—
3.97M
Jun 24
Form 3
—
0
—
—
0
No matching records found

GENOCEA BIOSCIENCES, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Feb 26
Form 4
∞
2.13M
$12.00
—
2.13M
Feb 10
Form 3
—
0
—
—
0
No matching records found

Disc Medicine, Inc. (IRON) Snapshot price: $65.73

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+112.05%
222.22K
$36.00
$8,000,028.00
420.55K
Jun 17
Form 4
—
0
—
—
0
Jun 12
Form 4
-3.72%
-26.16K
$73.50
-$1,922,539.50
677.5K
Mar 5
Form 4
-10.20%
-102.50K
$67.65
-$6,934,125.00
901.99K
Jan 23
Form 4
-2.48%
-20.00K
$64.00
-$1,280,000.00
786.16K
Jan 10
Form 4
-8.62%
-76.06K
$61.45
-$4,673,759.31
806.16K
Dec 12 - Dec 14
Form 4
-7.64%
-72.93K
$52.40
-$3,821,584.40
882.22K
Aug 15
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Dec 29
Form 3
—
0
—
—
0
No matching records found